NewCures is a biomedical accelerator that focuses on the development of potential therapeutics from Northwestern University laboratories. Its mission is to strengthen Northwestern’s therapeutic pipeline and to expedite the translational process of early-stage research discoveries into next generation therapeutics to ultimately benefit patients.
By aligning with industry standards, NewCures fills a translational gap in therapeutic development and aims to enhance and de-risk discoveries by:
- Identifying potential assets;
- Providing expertise and resources to formulate a strategic, project-specific development plan;
- Developing pertinent and robust preclinical data; and
- Translating research to industry-ready assets to attract external partnerships and investment from the private sector.
The programmatic structure of NewCures also serves to promote the exchange of knowledge related to pre-clinical therapeutic development at Northwestern.